TIAA CREF Investment Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

TIAA CREF Investment Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,460	Closed	-$152K	–	3242
2016 Q1	$152K	Hold	14,460	–	–	﹤0.01%	3013
2015 Q4	$427K	Hold	14,460	–	–	﹤0.01%	2945
2015 Q3	$457K	Buy	14,460 +2,088	+17%	+$99.9K	﹤0.01%	2912
2015 Q2	$732K	Buy	12,372 +1,155	+10%	+$81.5K	﹤0.01%	2841
2015 Q1	$1.2M	Sell	11,217 -10,710	-49%	-$1.02M	﹤0.01%	2518
2014 Q4	$2.06M	Sell	21,927 -304	-1%	-$29K	﹤0.01%	2206
2014 Q3	$1.71M	Buy	22,231 +5,083	+30%	+$400K	﹤0.01%	2325
2014 Q2	$1.54M	Buy	17,148 +10,562	+160%	+$647K	﹤0.01%	2454
2014 Q1	$352K	Hold	6,586	–	–	﹤0.01%	3026
2013 Q4	$166K	Hold	6,586	–	–	﹤0.01%	3096
2013 Q3	$180K	Buy	6,586 +138	+2%	+$4.44K	﹤0.01%	3059
2013 Q2	$233K	Buy	+6,448	New	+$242K	﹤0.01%	3037

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TIAA CREF Investment Management's PTX Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 14,460 shares — an estimated $152K sold.

TIAA CREF Investment Management first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $2.06M in Q4 2014. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

TIAA CREF Investment Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
TIAA CREF Investment Management sold 14,460 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $152K.
TIAA CREF Investment Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
TIAA CREF Investment Management's Pernix Therapeutics Holdings, Inc. position peaked at $2.06M in Q4 2014.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.